Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Omar Maoujoud, Samir Ahid & Yahia Cherrah. (2016) The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients. International Journal of Nephrology and Renovascular Disease 9, pages 35-43.
Read now
Read now
Articles from other publishers (7)
Nicole Brenner, Anuhya Kommalapati, Muhammad Ahsan & Anirban Ganguli. (2019) Red cell transfusion in chronic kidney disease in the United States in the current era of erythropoiesis stimulating agents. Journal of Nephrology 33:2, pages 267-275.
Crossref
Crossref
Luiz H. ArantesJr.Jr., Jeffrey Crawford, Pere Gascon, Mark Latymer, Vincent Launay-Vacher, Catherine Rolland, Florian Scotte & Jay Wish. (2018) A quick scoping review of efficacy, safety, economic, and health-related quality-of-life outcomes of short- and long-acting erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia and chronic kidney disease anemia. Critical Reviews in Oncology/Hematology 129, pages 79-90.
Crossref
Crossref
Thomas Ferguson, Yang Xu, Ravindi Gunasekara, Blake Lerner, Kerry Macdonald, Claudio Rigatto, Navdeep Tangri & Paul Komenda. (2015) The Cost Effectiveness of Erythropoietin-Stimulating Agents for Treating Anemia in Patients on Dialysis: A Systematic Review. American Journal of Nephrology 41:2, pages 89-97.
Crossref
Crossref
Joseph Menzin, Lisa M. Lines, Daniel E. Weiner, Peter J. Neumann, Christine Nichols, Lauren Rodriguez, Irene Agodoa & Tracy Mayne. (2011) A Review of the Costs and Cost Effectiveness of Interventions in Chronic Kidney Disease. PharmacoEconomics 29:10, pages 839-861.
Crossref
Crossref
Brooke S. Harrow, C.B. Eaton, M.B. Roberts, A.R. Assaf, Xuemei Luo & Zhao Chen. (2011) Health Utilities Associated with Hemoglobin Levels and Blood Loss in Postmenopausal Women: The Women's Health Initiative. Value in Health 14:4, pages 555-563.
Crossref
Crossref
A. Sanz-Granda. (2009) Análisis probabilístico de minimización de costes de darbepoetin alfa frente a epoetina alfa en el tratamiento de la anemia secundaria a insuficiencia renal crónica. Valoración en la práctica clínica española. Farmacia Hospitalaria 33:4, pages 208-216.
Crossref
Crossref
A. Sanz-Granda. (2009) Probabilistic cost-minimisation analysis of darbepoetin alpha versus epoetin alpha in treating anaemia secondary to chronic renal failure. Assessment in Spanish clinical practice. Farmacia Hospitalaria (English Edition) 33:4, pages 208-216.
Crossref
Crossref